Delhi: Central Bureau Of Narcotics Busts Illegal Drug Manufacturing Factory

New Delhi: The Central Bureau of Narcotics has busted an illegal drug manufacturing factory in the national capital selling Tramadol in disguise of ayurvedic medicines, the agency informed on Wednesday.

In an official statement, the agency said, “Acting on the said specific information joint Preventive team of Central Bureau of Narcotics New Delhi and Gwalior conducted a raid at Plot No. 93, Pocket G, Sector 5, Bawana Industrial Area, New Delhi and at Balaji Ayurvedic Store, Janta Bhawan Road, Sirsa (Haryana) and unearthed a clandestine Tramadol manufacturing unit at Bawana Industrial Area, New Delhi.”

Tramadol is an opioid analgesic of the same family of drugs as medications like oxycodone and hydrocodone, considering its misuse for addiction purposes Government has declared it as Psychotropic Substance in April 2018.

As per the agency, the said manufacturing unit was running in disguise of a honey processing plant and manufactured Tramadol Tablets were branded as Ayurvedic medicine.

“The search of the said premises resulted in the recovery of approx. 52.245 Kgs Tramadol pills and powder and 1.08 Kgs of substance suspected to be opium,” they said.

  • Related Posts

    • Pharma
    • December 23, 2024
    • 82 views
    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

    • Pharma
    • December 23, 2024
    • 114 views
    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt